Israeli Researchers Develop First mRNA Vaccine Against Antibiotic-Resistant Bacteria
TL;DR
Israeli researchers from Tel Aviv University have developed the world's first mRNA-based vaccine against Yersinia pestis, the bacterium causing bubonic plague, demonstrating 100% protection in animal models and highlighting its potential for preventing deadly bacterial infections and bioterrorism threats.
Topics:top-newshealth-and-wellness#bacterium#black-plague#covid-19#health-and-wellness#mrna-vaccine#yersinia-pestis
- Israeli researchers develop world's first mRNA-based vaccine against bacterium The Jerusalem Post
- In first, Israeli researchers develop mRNA jab against antibiotic-resistant bacterium The Times of Israel
- From COVID to pneumonic plague: mRNA vaccine scores another win with 100% effectiveness The Times of India
- COVID-19 vaccine technology adapted to develop first mRNA defense against antibiotic-resistant bacteria Medical Xpress
Want the full story? Read the original reporting
Read on The Jerusalem Post